GlobalData on MSN
BD secures FDA 510(k) clearance for EnCor EnCompass system
BD expects to bring the system to market in early 2026.
BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.
BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S.
SALT LAKE CITY--(BUSINESS WIRE)-- Healthcare reform, new compliance regulations, and the move to outcomes-based payment are putting pressure on clinical documentation and coding processes at hospitals ...
SALT LAKE CITY--(BUSINESS WIRE)--3M Health Information Systems is expanding its market-leading 3M 360 Encompass System platform to introduce 3M 360 Encompass System – Professional, the industry’s ...
The 3M™ 360 Encompass™ System seamlessly integrates CAC, CDI, concurrent quality metrics, and analytics to capture, analyze, and advance patient information across the continuum of care SANTA CLARA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results